← Back to Search

Behavioural Intervention

Digital Therapy for Depression and Anxiety

N/A
Recruiting
Led By Jill Palmer
Research Sponsored by Toivoa Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Presence of self-reported hearing or mobility disability
Be older than 18 years old
Must not have
Medical diagnosis of psychotic disorder or bipolar disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test Rauha, a new digital therapy, on people with disabilities who have anxiety and/or depression. The study will look at how many people finish the program, ask for feedback from

Who is the study for?
This trial is for individuals with physical disabilities who are experiencing anxiety and/or depression. Participants should be willing to complete the Rauha digital therapeutic program and provide feedback on their experience.
What is being tested?
The study is testing Rauha, an experimental digital therapy designed to help people with disabilities manage anxiety and depression. It will track how many finish the program and measure any changes in their mental health.
What are the potential side effects?
Since Rauha is a digital therapeutic, traditional medication side effects are not expected. However, users may experience discomfort or frustration if they find the program unhelpful or challenging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have difficulty hearing or moving around on my own.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with a psychotic disorder or bipolar disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Therapy dropout rates as a percentage of enrolled participants
Secondary study objectives
Changes in numeric GAD-7 Assessment scores following therapy.
Changes in numeric PHQ-9 Assessment scores following therapy.
Changes of numeric GAD-7 Assessment scores from completion through 4-weeks post therapy.
+1 more
Other study objectives
System Usability Survey
User Acceptability Survey
User Experience Survey

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Active Rauha TherapyExperimental Treatment1 Intervention
Qualified intend to treat (ITT) population evaluating Rauha and access to Mental Health Coaches

Find a Location

Who is running the clinical trial?

Family Endeavors, Inc DBA EndeavorsUNKNOWN
Advarra, Inc.UNKNOWN
Toivoa IncLead Sponsor
Jill PalmerPrincipal InvestigatorCollaborator
~27 spots leftby Dec 2025